Cardiovascular
Antihypertensives, lipid regulators and antiplatelet therapies for long-term chronic care.
Swiss Cure Pharmaceutical develops, manufactures and markets quality medicines trusted by healthcare professionals across Europe and beyond.
Swiss Cure Pharmaceutical was established in Lisbon in 2015 with a single conviction: that reliable medicine begins with uncompromising process. What started as a small formulation team has grown into an integrated company spanning development, manufacturing, regulatory affairs and commercial operations.
We work in the space between science and access — building products that meet strict European regulatory expectations while remaining affordable for the health systems that depend on them.
Our portfolio focuses on established, high-need categories where consistent quality matters most.
Antihypertensives, lipid regulators and antiplatelet therapies for long-term chronic care.
Antibiotics and antifungals produced under dedicated containment and cross-contamination controls.
Treatments supporting neurological and psychiatric care, with strict batch-to-batch consistency.
Acid suppression, motility and digestive health products in solid and liquid oral forms.
Topical formulations developed in our semi-solids suite, from corticosteroids to antifungals.
Analgesic and anti-inflammatory products covering both acute and chronic indications.
A selection from our registered range. Full product dossiers are available to partners on request.
Active ingredient · strength · form
Active ingredient · strength · form
Active ingredient · strength · form
Active ingredient · strength · form
Development, production, quality control and distribution, under one integrated operation.
Every batch is traceable from raw material to patient. Our quality system is built around continuous verification, not final inspection.
Facilities audited and certified under European Good Manufacturing Practice.
Documented processes reviewed and improved on a continuous cycle.
Unit-level traceability compliant with the EU Falsified Medicines Directive.
Dedicated safety team monitoring products throughout their market life.
We collaborate with distributors, licence holders and healthcare institutions across three models.
Territory-exclusive agreements for partners with established pharmacy and hospital channels.
Dossier licensing in both directions, with full regulatory support through registration.
Available capacity across solid oral, semi-solid and liquid forms under your brand.
For partnership enquiries, regulatory documentation or medical information, reach our team directly.
Your message has been received. Our team will get back to you within two business days.